Biotech ETFs Surge After Invitae Acquires ArcherDX
June 22, 2020 at 17:35 PM EDT
Biotechnology sector-related exchange traded funds were among the leaders on Monday after Invitae Corp. (NYSE: NVTA) announced a $1.4 billion deal for ArcherDX, potentially bolstering the genetic information company’s offering lineup and growth outlook. Among the best performing non-leveraged...